OncoNano Medicine
PrivateLast Round
Series B
Extension
Jun 2, 2025
Est. Valuation
$60M
Total Funding Raised
$216.27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoNano Medicine is a biotechnology company that develops pH-activated compounds designed to detect and treat diseased tissue, with a focus on enhancing cancer treatment during surgery and post-operative evaluation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoNano Medicine Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
OncoNano Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jun 2, 2025 | ||||
| Series B | Oct 25, 2021 | ||||
| Series B | Jun 17, 2021 | ||||
| Grant | Aug 20, 2020 | ||||
| Grant | Aug 27, 2019 | ||||
Series A | Jul 9, 2019 |
Key People
Founding team and executive leadership
OncoNano Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Advantech Capital | Series B |
| Salem Partners | Series B Extension, Series A |
| Cancer Prevention and Research Institute of Texas | Grant, Series B |
| Cancer Prevention and Research Institute of Texas (CPRIT) | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Presenting preclinical data at the AACR Annual Meeting 2026.
- Jan 6, 2026
Partnering with Gilead Sciences to evaluate encapsulation technology.
OncoNano Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoNano Medicine's valuation, stock price, and market status.